Precision Vaccinations (PVax) is an international publisher of research-based information people can trust to make informed vaccination decisions. PVax's innovative publishing model ... the 'Wiki for Vaccines ... integrates science-based, fact-checked information into the continually enhanced vaccine library.
Our goals are to facilitate main-street conversations between healthcare providers and patients regarding which vaccine is best for each person. And publish vaccine information people can actually understand!
We have been 'fact-checking' vaccine information for years and believe publishers must earn their readers' trust ....every day!
Publish trustworthy information empowering people to live life to the fullest!
PVax Digital Network
PVax Vaccine Library
PVax's vaccine library integrates peer-reviewed information from the European Medicines Agency, the World Health Organization, the UK, India, China, Brazil, Australia, and other agencies. Furthermore, PVax increases clinical trial transparency by integrating study results. And we curate our content to enhance consumer understanding by targeting the 10th-grade reading language.
More Than COVID-19 Vaccine Information
As the entire world confronted the COVID-19 pandemic, most people asked which vaccines were safe and effective. Recently, the World Health Organization said, 'vaccine misinformation is a significant threat to global health that could reverse decades of progress in tackling preventable diseases.
As of January 2022, the U.S. FDA has Approved numerous vaccines that protect people against various infections that cause disease. We believe digital publishers are responsible for ensuring people access research-based facts about these vaccines.'
In December 2021, PVax launched the first patient-centric vaccine rating app. This proprietary data helps guide content editing and syndication strategies.
Superior Content Management System
PVax's proprietary content management system empowers the 3rd generation of multi-brand, producer-controlled syndication networks, delivering superior mobile-user experiences. In addition, the CHAD 3.2 digital environment maximizes AI utility throughout PVax's fact-checked information network.
- Trusted - only licensed providers edit our content, delivering 100% transparency
- Understandable - our clinical information is written with a positive voice, translated into "main street" conversation
- Breaking research is contextually integrated into the news as it is published;
- Experience - each article is designed with uniform navigation, offering a consistent learning experience
Did You Know
- 93% of patients read online news
- 82% of adults surveyed said they seek out trustworthy news
- 39% of people trust information from providers
- 37% of seniors now get vaccinations from pharmacies
- 22% of press releases exaggerate causal claims from correlational findings in observational studies.
Vaccine Market Overview
Life-saving vaccines have had a profound impact on the world. Globally, millions of fewer deaths occur because vaccines protect people from disease. Today, almost anyone can be immunized against deadly diseases.
According to the CDC, almost 3.5 billion vaccine doses have been distributed in the United States over the past ten years. And research says that for every $1 spent on vaccines, $3 indirect benefits are realized from an economic perspective. New research projects the overall vaccine market will reach about $149 billion by 2026.
And since the Human Genome Project's success in 2000, people have been gaining awareness of their genetic makeup and ways to enhance their quality of life. Soon, the promise of personalized vaccines will become a reality, disrupting the one-size-fits-all vaccination model.
PV publishes breaking news posts, featured news articles, disease information channels, and an extensive vaccine library. These pages are reviewed for relevance and accuracy daily.
PV supports these industry-leading non-profit health publishing criteria:
Inclusiveness is at the heart of thinking and acting as journalists. The complex issues we face as a society require respect for different viewpoints. Race, class, generation, gender, and geography affect perspective. Reflecting these differences in our reporting leads to better, more nuanced stories and a better-informed community. Therefore, we seek diverse voices in our management and reporting staff.
Precision Vax publishes vaccine information based upon valid research from universities, government agencies, pharmaceutical manufacturers, and the WHO. Furthermore, these organizations' editorial biases do not influence PV's independently published content. PV cites potential conflicts of interest on the same page as the published, relevant work.
PV's digital newsroom is insulated from any interaction with advertisers. We do not accept gifts or remuneration to avoid any conflicts. And our news-gathering team is independent of commercial or political interests. Additionally, we do not allow third-parties to "ghost-write" news articles.
If you have any questions, contact [email protected].
Medical Advisory Team
The Medical Advisory Team works closely with pharmacists, doctors, and nurses across various specialty areas to ensure PrecisionVax's published content is accurate, actionable, and understandable. If you have any questions, please contact Dr. Robert Carlson, [email protected].
Our news team has been fact-checking health news for over 20 years and commits to doing its best to publish accurate information. We stand by the information we publish, and if it's not correct, we will change it as quickly as possible. In addition, we take many steps to ensure accuracy, such as:
- We investigate claims with skepticism; question assumptions; challenge conventional wisdom;
- We confirm information with subject-matter experts and seek to corroborate what sources tell us by talking with other informed people or consulting documents;
- We verify content, such as technical terms, stats, etc., against source documents or clarify who provides the information. For example, we may share relevant components of a story with a primary source or an outside expert to verify them.
Various PVax policies are listed on this webpage.
Precision Vax, LLC is a 100% woman-owned private enterprise founded in 2016. Karen McClorey Hackett, Precision Vax's president, is committed to transparency in our ownership structure and revenue sources. Karen launched her career with IBM and has invested in digital health enterprises since 1997. Here is Karen's Linkedin profile.
We primarily produce our revenues from advertising. Our dominant digital advertiser is Google Adsense. As such, our editorial team has no relationship or communications with any advertiser.
Please note that advertising networks such as Adsense integrates user-tracking capabilities that may not be obvious to users. Google Ads Terms & Conditions are published at this link.
PVax also integrates lead generation business agreements for clinical trials, diagnostic tests, and vaccine appointments.
Comments and Concerns
We believe that public feedback is not a one-way street. Instead, we are committed to engaging with you and taking action based on your suggestions and other feedback. We are committed to providing greater transparency about how news is produced and offering regular contact and interaction points. In addition, we believe that news organizations are responsible for engaging with the public on the values and issues daily.
We will respond to your request within two business days. Would you mind sending an email to [email protected]?
Karen Hackett, Founder & President